tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Laura Sutcliffe, 20 are a BUY (40.82%), 29 are a HOLD (59.18%).
Analyst Laura Sutcliffe, currently employed at UBS, carries an average stock price target met ratio of 37.5% that have a potential upside of 9.49% achieved within 163 days.
Laura Sutcliffe’s has documented 96 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GSK, GlaxoSmithKline PLC ADR at 08-Jul-2024.
Analyst best performing recommendations are on RMD (RESMED).
The best stock recommendation documented was for GLPG (GALAPAGOS NV ADR) at 5/18/2020. The price target of $217.34 was fulfilled within 3 days with a profit of $5.27 (2.37%) receiving and performance score of 7.89.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$30
$3.24 (12.11%)
$38
1 months 25 days ago
(01-Nov-2024)
11/14 (78.57%)
$3.11 (11.57%)
23
Hold
$38
$11.24 (42.00%)
$38
8 months 4 days ago
(22-Apr-2024)
0/2 (0%)
$8.93 (30.72%)
Sell
$31
$4.24 (15.84%)
$44
8 months 25 days ago
(01-Apr-2024)
6/9 (66.67%)
$-1.48 (-4.56%)
14
Hold
$37
$10.24 (38.27%)
$40
1 years 21 days ago
(05-Dec-2023)
11/13 (84.62%)
$-1.79 (-4.61%)
22
Hold
$44.45
$17.69 (66.11%)
$73.23
1 years 4 months 2 days ago
(24-Aug-2023)
0/2 (0%)
$7.09 (18.98%)
Which stock is Laura Sutcliffe is most bullish on?
What Year was the first public recommendation made by Laura Sutcliffe?
